StemCyte International, Ltd. (TWSE: 4178)
Health Care · Biotechnology · TW
NT$19.60
+8.89% today · -14.4% 1Y
StemCyte International, Ltd. (TWSE: 4178) operates in the Biotechnology industry within the Health Care sector. The company is valued at $132.32M.
Over the last twelve months the share price has lost 14.4%, trading between 16.00 and 34.10.
Tweenvest scores StemCyte International, Ltd. across four factors: quality 73/100, value 55/100. Its strongest factor is quality.
4178 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $132.32M
- Revenue (TTM)
- $11.41M
- P/E
- —
- EPS
- -0.88
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$34.10
- 52-week low
- NT$16.00
- Avg volume (3M)
- —
- Shares outstanding
- 215.87M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Korro Bio, Inc.NasdaqCM: KRRO | $137.98M | $9.37 | -7.78% |
| Armata Pharmaceuticals, Inc.NYSEAM: ARMP | $134.97M | $3.58 | -1.38% |
| Innate Pharma S.A.ENXTPA: IPH | $134.19M | €1.28 | -1.54% |
| NIBEC Co., Ltd.KOSDAQ: A138610 | $132.33M | ₩15,650.00 | -2.07% |
| Saniona AB (publ)OM: SANION | $132.11M | Skr9.57 | -0.26% |
| Orthocell LimitedASX: OCC | $131.16M | AU$0.69 | -9.21% |
| Tenaya Therapeutics, Inc.NasdaqCM: TNYA | $130.12M | $0.57 | -2.55% |
| NKGen Biotech Korea Co., Ltd.KOSDAQ: A182400 | $128.86M | ₩— | — |
Figures last refreshed Oct 11, 2026.